Radiation and chemo may spare rectal cancer patients from surgery
NCT ID NCT02438839
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a combination of radiation and chemotherapy can cure low rectal cancer, allowing patients to avoid surgery. About 108 people with early-stage rectal tumors near the anus will receive this treatment. The main goal is to see if the cancer stays under control in the pelvis two years after treatment ends.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Oncology, Aalborg University Hospital
Aalborg, Denmark
-
Department of Oncology, Rigshospitalet
Copenhagen, Denmark
-
Department of Oncology, Vejle Hospital
Vejle, Denmark
-
Department of Surgery, Aalborg University Hospital
Aalborg, Denmark
-
Department of Surgery, Vejle Hospital
Vejle, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can diet and vitamin c supercharge rectal cancer treatment?
- Digital nurse companion: could an app ease the burden of chronic illness?
- Which rectal cancer surgery preserves quality of life better? a study investigates
- AI as a surgical Co-Pilot: predicting difficulty in rectal cancer
- Can AI learn to grade endoscopy quality from video?
- Can precision protons spare rectal cancer patients from harsh side effects?